Copyright
©The Author(s) 2024.
World J Psychiatry. Jan 19, 2024; 14(1): 88-101
Published online Jan 19, 2024. doi: 10.5498/wjp.v14.i1.88
Published online Jan 19, 2024. doi: 10.5498/wjp.v14.i1.88
Target | Common name | Target class | Probability |
Bradykinin B1 receptor | BDKRB1 | Family A G protein-coupled receptor | 0.420 |
Neurotensin receptor 1 | NTSR1 | Family A G protein-coupled receptor | 0.189 |
Thrombin | F2 | Protease | 0.169 |
HLA class I histocompatibility antigen A-3 | HLA-A | Surface antigen | 0.140 |
Mu opioid receptor | OPRM1 | Family A G protein-coupled receptor | 0.131 |
Delta opioid receptor | OPRD1 | Family A G protein-coupled receptor | 0.131 |
Kappa opioid receptor | OPRK1 | Family A G protein-coupled receptor | 0.122 |
Neurotensin receptor 2 | NTSR2 | Family A G protein-coupled receptor | 0.122 |
HLA class II histocompatibility antigen DRB3-1 | HLA-DRB3 | Surface antigen | 0.122 |
Cyclin-dependent kinase 2/cyclin A | CDK2, CCNA1, CCNA2 | Other cytosolic protein | 0.122 |
- Citation: Huang ZY, Lyu ZP, Li HG, You HZ, Yang XN, Cha CH. Des-Arg(9) bradykinin as a causal metabolite for autism spectrum disorder. World J Psychiatry 2024; 14(1): 88-101
- URL: https://www.wjgnet.com/2220-3206/full/v14/i1/88.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i1.88